Profile data is unavailable for this security.
About the company
YungShin Global Holding Corp is a Taiwan-based company mainly engaged in the manufacture and sale of human pharmaceutical medicine and animal medicine. The Company mainly invests in the manufacturing and trading of various medicines, animal medicines, Chinese medicines, health foods, chemicals, cosmetics, soaps, medicated soaps, various detergents, spices, feeds, diagnostic equipment and reagents. The Company also invests in the sales of pharmaceuticals, pharmaceutical raw materials and health food raw materials, as well as the production and sales of chemical drugs and feed additives and other animal products. The main products are antibiotic injection items, various aqueous solutions for medicine and oral tablets of antibiotics, veterinary drug products, medicated feed additives and non-medicated feed additives and others.
- Revenue in TWD (TTM)7.44bn
- Net income in TWD1.05bn
- Incorporated2011
- Employees1.57k
- LocationYungShin Global Holding Corp25F-1No. 402, Shizheng Road, Xitun DistrictTAIPEI 105TaiwanTWN
- Phone+886 225450185
- Fax+886 225450586
- Websitehttp://www.yungshingroup.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adimmune Corp | 1.66bn | -607.92m | 9.51bn | 564.00 | -- | 1.86 | -- | 5.74 | -1.44 | -1.44 | 3.93 | 11.92 | 0.1848 | 1.25 | 4.04 | -- | -8.27 | 0.6867 | -10.19 | 0.7739 | 27.82 | 30.11 | -44.75 | 3.04 | 1.99 | -24.75 | 0.3284 | 32.80 | -20.72 | 16.77 | -319.91 | -- | 38.05 | -- |
| Formosa Laboratories Inc | 4.69bn | 255.94m | 10.94bn | 480.00 | 43.10 | 1.46 | 18.23 | 2.33 | 2.11 | 2.11 | 38.90 | 62.49 | 0.3479 | 1.49 | 4.42 | -- | 0.7067 | 2.68 | 0.9689 | 3.61 | 44.30 | 35.40 | 2.03 | 8.75 | 1.18 | 0.8922 | 0.3155 | 27.38 | 15.80 | 10.16 | -69.16 | -6.52 | -11.60 | 32.22 |
| Standard Chem & Pharm Co Ltd | 6.71bn | 847.58m | 11.37bn | 1.13k | 13.42 | 1.92 | 7.10 | 1.69 | 4.74 | 4.74 | 37.50 | 33.05 | 0.6066 | 2.39 | 6.00 | -- | 10.98 | 9.68 | 20.02 | 17.61 | 43.81 | 43.75 | 18.10 | 17.02 | 1.93 | -- | 0.0795 | 60.34 | 6.64 | 11.80 | 2.39 | 17.40 | 29.97 | 12.47 |
| SCI Pharmtech Inc | 1.41bn | 484.24m | 11.47bn | 241.00 | 24.05 | 2.12 | 16.36 | 8.12 | 3.99 | 3.99 | 13.98 | 45.36 | 0.2211 | 1.82 | 4.61 | -- | 7.58 | 6.90 | 8.56 | 8.26 | 27.11 | 38.18 | 34.26 | 19.85 | 1.68 | 9.22 | 0.1692 | 42.38 | 33.83 | -9.10 | -4.55 | -8.00 | 44.67 | -16.35 |
| YungShin Global Holding Corp | 7.44bn | 1.05bn | 14.47bn | 1.57k | 13.74 | 1.96 | 10.18 | 1.95 | 3.95 | 3.95 | 27.91 | 27.66 | 0.5953 | 1.47 | 5.51 | -- | 9.10 | 6.64 | 13.58 | 10.20 | 43.28 | 45.11 | 15.29 | 10.45 | 1.35 | -- | 0.1034 | 70.94 | -3.88 | -1.33 | -1.40 | 3.34 | -29.00 | 0.893 |
| ScinoPharm Taiwan Ltd | 3.43bn | 403.00m | 18.42bn | 1.01k | 45.83 | 1.78 | 21.07 | 5.37 | 0.5084 | 0.5084 | 4.33 | 13.12 | 0.2871 | 1.27 | 6.63 | -- | 3.37 | 2.33 | 3.69 | 2.51 | 38.89 | 41.09 | 11.76 | 9.10 | 5.00 | -- | 0.0592 | 109.25 | -2.39 | -2.00 | -18.73 | -8.31 | 16.90 | -9.35 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 02 Oct 2024 | 7.80m | 2.67% |
| Dimensional Fund Advisors LPas of 03 Oct 2024 | 4.30m | 1.47% |
| BlackRock Fund Advisorsas of 03 Oct 2024 | 3.73m | 1.28% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 1.74m | 0.60% |
| BlackRock Advisors (UK) Ltd.as of 03 Oct 2024 | 690.94k | 0.24% |
| State Street Global Advisors Europe Ltd.as of 02 Oct 2024 | 536.00k | 0.18% |
| SSgA Funds Management, Inc.as of 03 Oct 2024 | 226.00k | 0.08% |
| American Century Investment Management, Inc.as of 31 Oct 2024 | 199.00k | 0.07% |
| RAM Active Investments SAas of 30 Jun 2024 | 193.00k | 0.07% |
| Dimensional Fund Advisors Ltd.as of 31 Aug 2024 | 185.96k | 0.06% |
